Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Company will host a Conference call for Analysts and Investors to discuss the un-audited financial results of the Company for the quarter and nine months ended December 31, 2023 on Friday, February 16, 2024 at 04:00 p.m. (IST) as per the details attached
10-02-2024
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Acquisition

 Acquistion of an additional stake of upto 5.89% of JC Biotech Private Limited (Subsidiary)
10-02-2024
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Statement Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31, 2023

 Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023
10-02-2024
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Board Meeting Outcome for Outcome Of Board Meeting Held On February 10, 2024

 This is to inform you that the Board of Directors at its Meeting held on February 10, 2024 has inter alia, approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023 and acquisition of an additional stake of upto 5.89% of JC Biotech Private Limited
10-02-2024
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31, 2023.

 Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2024 ,inter alia, to consider and approve Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2023.
03-02-2024
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Advanced Vital Enzymes Pvt Ltd
10-01-2024
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Advanced Vital Enzymes Pvt Ltd
09-01-2024
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74(5) of SEBI(DP) Regulations, 2018
08-01-2024
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet - Sundaram Asset Management Company
03-01-2024
Bigul

Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Analyst/ Investor meet - Value Quest
02-01-2024
Next Page
Close

Let's Open Free Demat Account